Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present study, we demonstrate that
leupaxin
mRNA is overexpressed in prostate cancer (PCa) as compared with normal prostate tissue by using cDNA arrays and quantitative RT-PCR analyses. Moderate to strong expression of
leupaxin
protein was detected in approximately 22% of the PCa tissue sections analyzed, and
leupaxin
expression intensities were found to be significantly correlated with Gleason patterns/scores. In addition, different
leupaxin
expression levels were observed in PCa cell lines, and at the subcellular level,
leupaxin
was usually localized in focal adhesion sites. Furthermore, mutational analysis and transfection experiments of LNCaP cells using different green fluorescent protein-
leupaxin
constructs demonstrated that
leupaxin
contains functional nuclear export signals in its LD3 and LD4 motifs, thus shuttling between the cytoplasm and the nucleus. We could also demonstrate for the first time that
leupaxin
interacts with the androgen receptor in a ligand-dependent manner and serves as a
transcriptional activator
of this hormone receptor in PCa cells. Down-regulation of
leupaxin
expression using RNA interference in LNCaP cells resulted in a high rate of morphological changes, detachment, spontaneous apoptosis, and a reduction of prostate-specific antigen secretion. In contrast, knockdown of
leupaxin
expression in androgen-independent PC-3 and DU 145 cells induced a significant decrease of both the invasive capacity and motility. Our results therefore indicate that
leupaxin
could serve as a potential progression marker for a subset of PCa and may represent a novel coactivator of the androgen receptor.
Leupaxin
could function as a putative target for therapeutic interventions of a subset of advanced PCa.
...
PMID:Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells. 1845 Oct 96